Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Potentially preventable trauma deaths: A retrospective review.

Beck B, Smith K, Mercier E, Bernard S, Jones C, Meadley B, Clair TS, Jennings PA, Nehme Z, Burke M, Bassed R, Fitzgerald M, Judson R, Teague W, Mitra B, Mathew J, Buck A, Varma D, Gabbe B, Bray J, McLellan S, Ford J, Siedenburg J, Cameron P.

Injury. 2019 May;50(5):1009-1016. doi: 10.1016/j.injury.2019.03.003. Epub 2019 Mar 7.

2.

On-Line NIR to Regulate Pervaporation Process: Application for Dehydration.

La Rocca T, Carretier E, Clair T, Etienne M, Moulin P.

Membranes (Basel). 2018 Sep 4;8(3). pii: E74. doi: 10.3390/membranes8030074.

3.
4.

Phospholipase Cgamma activation drives increased production of autotaxin in endothelial cells and lysophosphatidic acid-dependent regression.

Im E, Motiejunaite R, Aranda J, Park EY, Federico L, Kim TI, Clair T, Stracke ML, Smyth S, Kazlauskas A.

Mol Cell Biol. 2010 May;30(10):2401-10. doi: 10.1128/MCB.01275-09. Epub 2010 Mar 15.

5.

For science, no escape from politics.

Clair T.

Science. 2009 Mar 6;323(5919):1288. doi: 10.1126/science.323.5919.1288a. No abstract available.

PMID:
19265000
6.

Novel point mutations attenuate autotaxin activity.

Koh E, Bandle RW, Roberts DD, Stracke ML, Clair T.

Lipids Health Dis. 2009 Feb 17;8:4. doi: 10.1186/1476-511X-8-4.

7.

Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis?

Zhao C, Fernandes MJ, Prestwich GD, Turgeon M, Di Battista J, Clair T, Poubelle PE, Bourgoin SG.

Mol Pharmacol. 2008 Feb;73(2):587-600. Epub 2007 Nov 15.

PMID:
18006645
8.

Sphingosine-1-phosphate initiates rapid retraction of pseudopodia by localized RhoA activation.

Koh E, Clair T, Hermansen R, Bandle RW, Schiffmann E, Roberts DD, Stracke ML.

Cell Signal. 2007 Jun;19(6):1328-38. Epub 2007 Jan 19.

PMID:
17307336
9.

Trichostatin A and 5-aza-2'-deoxycytidine switch S1P from an inhibitor to a stimulator of motility through epigenetic regulation of S1P receptors.

Koh E, Bandle R, Clair T, Roberts DD, Stracke ML.

Cancer Lett. 2007 May 18;250(1):53-62. Epub 2006 Dec 26.

PMID:
17189669
10.

Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.

Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, Li CC, Tan TH, Colburn NH.

Mol Cell Biol. 2006 Feb;26(4):1297-306.

11.

The candidate tumor suppressor CST6 alters the gene expression profile of human breast carcinoma cells: down-regulation of the potent mitogenic, motogenic, and angiogenic factor autotaxin.

Song J, Jie C, Polk P, Shridhar R, Clair T, Zhang J, Yin L, Keppler D.

Biochem Biophys Res Commun. 2006 Feb 3;340(1):175-82. Epub 2005 Dec 9.

PMID:
16356477
12.

Estimation of critical loads of acidity for lakes in northeastern United States and eastern Canada.

Dupont J, Clair TA, Gagnon C, Jeffries DS, Kahl JS, Nelson SJ, Peckenham JM.

Environ Monit Assess. 2005 Oct;109(1-3):275-92.

PMID:
16240203
13.

Sulphate, nitrogen and base cation budgets at 21 forested catchments in Canada, the United States and Europe.

Watmough SA, Aherne J, Alewell C, Arp P, Bailey S, Clair T, Dillon P, Duchesne L, Eimers C, Fernandez I, Foster N, Larssen T, Miller E, Mitchell M, Page S.

Environ Monit Assess. 2005 Oct;109(1-3):1-36.

PMID:
16240186
14.

Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate.

Song J, Clair T, Noh JH, Eun JW, Ryu SY, Lee SN, Ahn YM, Kim SY, Lee SH, Park WS, Yoo NJ, Lee JY, Nam SW.

Biochem Biophys Res Commun. 2005 Nov 25;337(3):967-75. Epub 2005 Oct 3.

PMID:
16219296
15.

Physical controls on total and methylmercury concentrations in streams and lakes of the northeastern USA.

Shanley JB, Kamman NC, Clair TA, Chalmers A.

Ecotoxicology. 2005 Mar;14(1-2):125-34.

PMID:
15931963
16.

Distribution patterns of mercury in lakes and rivers of northeastern North America.

Dennis IF, Clair TA, Driscoll CT, Kamman N, Chalmers A, Shanley J, Norton SA, Kahl S.

Ecotoxicology. 2005 Mar;14(1-2):113-23.

PMID:
15931962
17.

Factors influencing mercury in freshwater surface sediments of northeastern North America.

Kamman NC, Chalmers A, Clair TA, Major A, Moore RB, Norton SA, Shanley JB.

Ecotoxicology. 2005 Mar;14(1-2):101-11.

PMID:
15931961
18.

Mercury in northeastern North America: a synthesis of existing databases.

Evers DC, Clair TA.

Ecotoxicology. 2005 Mar;14(1-2):7-14. Review.

PMID:
15931954
19.

Physiological mechanisms of tumor-cell invasion and migration.

Geho DH, Bandle RW, Clair T, Liotta LA.

Physiology (Bethesda). 2005 Jun;20:194-200. Review.

20.

Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides.

Olive C, Hsien K, Horváth A, Clair T, Yarwood P, Toth I, Good MF.

Vaccine. 2005 Mar 18;23(17-18):2298-303.

PMID:
15755615
21.

L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin.

Clair T, Koh E, Ptaszynska M, Bandle RW, Liotta LA, Schiffmann E, Stracke ML.

Lipids Health Dis. 2005 Feb 28;4:5.

22.

Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct.

Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF.

Indian J Med Res. 2004 May;119 Suppl:88-94.

PMID:
15232170
23.
24.

Changes in acid precipitation-related water chemistry of lakes from southwestern New Brunswick, Canada, 1986-2001.

Pilgrim W, Clair TA, Choate J, Hughes R.

Environ Monit Assess. 2003 Oct-Nov;88(1-3):39-52.

PMID:
14570410
25.

Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate.

Clair T, Aoki J, Koh E, Bandle RW, Nam SW, Ptaszynska MM, Mills GB, Schiffmann E, Liotta LA, Stracke ML.

Cancer Res. 2003 Sep 1;63(17):5446-53.

26.

Hydrolysis of diadenosine polyphosphates by nucleotide pyrophosphatases/phosphodiesterases.

Vollmayer P, Clair T, Goding JW, Sano K, Servos J, Zimmermann H.

Eur J Biochem. 2003 Jul;270(14):2971-8.

27.

Assessing the recovery of lakes in southeastern Canada from the effects of acidic deposition.

Jeffries DS, Clair TA, Couture S, Dillon PJ, Dupont J, Keller W, McNicol DK, Turner MA, Vet R, Weeber R.

Ambio. 2003 Apr;32(3):176-82.

PMID:
12839192
28.
29.

Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.

Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF.

Infect Immun. 2003 May;71(5):2373-83.

30.
32.

A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies.

Olive C, Batzloff MR, Horváth A, Wong A, Clair T, Yarwood P, Toth I, Good MF.

Infect Immun. 2002 May;70(5):2734-8.

33.

Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes.

Horvath A, Olive C, Wong A, Clair T, Yarwood P, Good M, Toth I.

J Med Chem. 2002 Mar 14;45(6):1387-90.

PMID:
11882009
34.
35.

Induction of multiple chemokine and colony-stimulating factor genes in experimental Burkholderia pseudomallei infection.

Barnes JL, Ulett GC, Ketheesan N, Clair T, Summers PM, Hirst RG.

Immunol Cell Biol. 2001 Oct;79(5):490-501.

PMID:
11564157
36.

Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor.

Nam SW, Clair T, Kim YS, McMarlin A, Schiffmann E, Liotta LA, Stracke ML.

Cancer Res. 2001 Sep 15;61(18):6938-44.

37.

Burkholderia pseudomallei virulence: definition, stability and association with clonality.

Ulett GC, Currie BJ, Clair TW, Mayo M, Ketheesan N, Labrooy J, Gal D, Norton R, Smith CA, Barnes J, Warner J, Hirst RG.

Microbes Infect. 2001 Jul;3(8):621-31.

PMID:
11445448
38.

Enzymatic activation of autotaxin by divalent cations without EF-hand loop region involvement.

Lee J, Jung ID, Nam SW, Clair T, Jeong EM, Hong SY, Han JW, Lee HW, Stracke ML, Lee HY.

Biochem Pharmacol. 2001 Jul 15;62(2):219-24.

PMID:
11389881
39.

A sensitive screening assay for secreted motility-stimulating factors.

Nam SW, Clair T, Schiffmann E, Liotta LA, Stracke ML.

Cell Motil Cytoskeleton. 2000 Aug;46(4):279-84.

PMID:
10962482
40.

Cripto-1-induced increase in vimentin expression is associated with enhanced migration of human Caski cervical carcinoma cells.

Ebert AD, Wechselberger C, Nees M, Clair T, Schaller G, Martinez-Lacaci I, Wallace-Jones B, Bianco C, Weitzel HK, Salomon DS.

Exp Cell Res. 2000 May 25;257(1):223-9.

PMID:
10854071
41.

Cancer. Checkpoint for invasion.

Liotta LA, Clair T.

Nature. 2000 May 18;405(6784):287-8. No abstract available.

PMID:
10830943
42.

Societal responsibilities.

Clair T.

Science. 2000 Jan 21;287(5452):428. No abstract available.

PMID:
10671169
43.

Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells.

Nam SW, Clair T, Campo CK, Lee HY, Liotta LA, Stracke ML.

Oncogene. 2000 Jan 13;19(2):241-7.

44.

Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase.

Mulvaney PT, Stracke ML, Nam SW, Woodhouse E, O'Keefe M, Clair T, Liotta LA, Khaddurah-Daouk R, Schiffmann E.

Int J Cancer. 1998 Sep 25;78(1):46-52.

45.

Adenosine receptor mediates motility in human melanoma cells.

Woodhouse EC, Amanatullah DF, Schetz JA, Liotta LA, Stracke ML, Clair T.

Biochem Biophys Res Commun. 1998 May 29;246(3):888-94.

PMID:
9618307
46.

Nucleotide binding to autotaxin: crosslinking of bound substrate followed by lysC digestion identifies two labeled peptides.

Clair T, Krutzsch HC, Liotta LA, Stracke ML.

Biochem Biophys Res Commun. 1997 Jul 18;236(2):449-54.

PMID:
9240459
47.

Autotaxin is an exoenzyme possessing 5'-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities.

Clair T, Lee HY, Liotta LA, Stracke ML.

J Biol Chem. 1997 Jan 10;272(2):996-1001.

48.

Autotaxin, tumor motility-stimulating exophosphodiesterase.

Stracke ML, Clair T, Liotta LA.

Adv Enzyme Regul. 1997;37:135-44.

PMID:
9381968
49.

Novel growth inhibitory effect of 8-Cl-cAMP is dependent on serum factors that modulate protein kinase A expression but not the hydrolysis of 8-Cl-cAMP.

Budillon A, Clair T, Hartman N, Strong J, Sobukawa Y, Miki K, Worby A, Murray K, Chochung Y.

Int J Oncol. 1996 Dec;9(6):1113-20.

PMID:
21541619
50.

Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin.

Lee HY, Clair T, Mulvaney PT, Woodhouse EC, Aznavoorian S, Liotta LA, Stracke ML.

J Biol Chem. 1996 Oct 4;271(40):24408-12.

Supplemental Content

Support Center